This trial is enrolling by invitation!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Iron Deficiency
and you are
between 18 and 75
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Primary Hypothesis - The 24-hour post-transfusion RBC recovery of units obtained from donors exhibiting iron-deficient erythropoiesis will not meet FDA standards for clinical use. - The 24-hour post-transfusion RBC recovery of units obtained after intravenous iron repletion will improve significantly and will meet FDA standards for clinical use.

Provided treatments

  • Drug: Iron-dextran
  • Drug: Saline
  • Procedure: Blood Donation
  • Procedure: 24-hour PTR

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02889133. The sponsor of the trial is Columbia University and it is looking for 60 volunteers for the current phase.
Official trial title:
A Randomized Trial to Determine if RBCs From Donors With Iron Deficient Erythropoiesis Have Decreased Post-transfusion RBC Recovery and Whether Iron Repletion Improves Recovery